Story
Dyne Therapeutics Stock Falls 9% After Pricing $375 Million Offering at a Discount

Shares of Dyne Therapeutics, Inc. (NASDAQ:DYN) fell by 9% in Wednesday morning trading after the company priced an upsized public offering of its common stock at a significant discount.
Offering Details
Dyne Therapeutics announced in a press release it had priced an offering of 18,300,000 shares of common stock at $20.50 per share. The company expects to raise gross proceeds of approximately $375.15 million before deducting underwriting discounts and other expenses.
The offering price represents a 14% discount to the stock's closing price of $23.83 on Tuesday. All shares are being sold by the company, and the offering is expected to close on or about July 23, 2026, subject to customary closing conditions.
AdMarket Impact and Context
The stock's decline is a direct market reaction to the dilutive nature of the offering and its discounted price. Secondary offerings increase the total number of shares outstanding, which can reduce the value of existing shares, and pricing below the market rate often causes the stock to trade down toward the new offering price.
Dyne also granted the underwriters a 30-day option to purchase up to an additional 2,745,000 shares at the public offering price. The joint book-running managers for the offering include Morgan Stanley, Jefferies, Evercore ISI, LifeSci Capital, and Raymond James.
Read next
More on Stocks
FTC Orders Walmart, Uber, Delta to Disclose Data on Personalized Pricing
The U.S. Federal Trade Commission is demanding nine major companies, including leading retail, travel, and gig economy firms, to provide information on how they use consumer data for setting individual prices and wages.

Google Launches Gemini 4 Carbon AI Model to Bolster Cybersecurity Capabilities
Alphabet's Google has unveiled Gemini 4 Carbon, its latest AI model specifically designed for advanced cybersecurity tasks like vulnerability detection and secure code generation. The launch escalates competition with rivals OpenAI and Anthropic in the enterprise AI market.

Oracle Shares Surge After Unveiling $225 Billion Revenue Target for 2030
Oracle stock rose sharply after the company presented a long-term financial outlook targeting at least $225 billion in annual revenue by fiscal 2030, driven by its expanding AI infrastructure business.

DOJ Scrutinizes Nvidia's $12.9B Hugging Face Deal Amid Broader Antitrust Probe, Sources Say
The U.S. Department of Justice is reportedly examining Nvidia's planned $12.93 billion acquisition of AI platform Hugging Face as part of a wider, ongoing antitrust investigation into the chipmaker's market conduct.